Results 61 to 70 of about 7,202 (139)

Hodgkin Reed-Sternberg Cells of Classic Hodgkin Lymphoma: Morphology, Phenotype, Genotype, and Cell of Origin. [PDF]

Cancers (Basel)
Gloghini A, Lorenzini D, Volpi CC, Trupia DV, Pruneri G.   +4 more
europepmc   +1 more source

Research note: Marek's disease oncogene Meq directly regulates CD30 high expression through binding to two regions in promoter. [PDF]

Poult Sci
Du Y, Zheng G, Yang Y, Zhang J, Li J, Lian L.   +5 more
europepmc   +1 more source

Immunotherapy in NK/T-Cell Lymphoma: Mechanisms, Clinical Evidence, Resistance, and Emerging Multimodal Strategies. [PDF]

Cancers (Basel)
Zhang Q, Wang X.
europepmc   +1 more source

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma. [PDF]

Front Immunol
Schlierkamp-Voosen T, Barden M, Janning H, Kaljanac M, Harrer DC, Dreger C, Hammon K, Ertelt M, Schoeder CT, Halldórsdóttir HR, Rodriguez-Pardo C, Hadrup SR, Thomas S, Abken H.   +13 more
europepmc   +1 more source

Predictors of sensitivity to immune therapies in classic Hodgkin lymphoma. [PDF]

Blood Neoplasia
Alibrahim MN, Carbone A, Gloghini A.
europepmc   +1 more source

Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's Lymphomas. [PDF]

J Cell Mol Med
Santa M, Cenariu D, Tigu AB, Damian M, Rantshabeng P, Gaolathe T, Ndlovu AK, Abdelrahman K, Nistor M, Kegyes D, Gulei D, Jinca C, Bancos A, Rus I, Bumbea H, Tomacinschii V, Buruiana S, Bilal R, Selicean C, Zdrenghea M, Fetica B, Stefan C, Fromm J, Tomuleasa C.   +23 more
europepmc   +1 more source

Harnessing the power of natural killer cells in Lymphoma immunotherapy: Overcoming challenges and enhancing treatment options. [PDF]

Hematol Transfus Cell Ther
Roshandel E, Lasemi MV, Mehravar M, Salimi M, Majidi M, Mohammadali F, Seraji HR, Hajifathali A.   +7 more
europepmc   +1 more source

Pathobiological link between CD30 and abnormal lymphocytes in adult T-cell leukemia/lymphoma. [PDF]

J Clin Exp Hematop
Horie R, Watanabe M, Furuta R, Miyazaki K, Watabnabe T.   +4 more
europepmc   +1 more source

CD30 knockout attenuates experimental colitis by reducing inflammatory cytokine production. [PDF]

BMC Immunol
Guo L, He Z, Yang C, Chen X, Wang J.
europepmc   +1 more source

Redirecting engineered immune cells using G protein-coupled receptors in cancer therapy. [PDF]

Immunooncol Technol
den Hartog W, Harwood J, Kobold S.
europepmc   +1 more source